To systematically characterize MYCN‐mediated metabolic reprogramming, we performed untargeted mass spectrometry (MS)‐based metabolomic analysis in CHP‐134 NB cells with or without MYCN sgRNA. Here, MYCN is linked to neuroblastoma.